Find out about our third-party funded projects

While our research is largely funded by the Max Planck Society, we actively and very successfully apply for competitive third-party grants, for example awarded by the European Research Council and the Deutsche Forschungsgemeinschaft (DFG). Thus we can implement and pursue still further projects in the field of ageing research.

Protein crystals under the microscope: proteins usually don't form crystals. But scientists make that happen by exposing the proteins to specific conditions. The crystals are then used for X-ray structure analysis to visualize how proteins look like and which binding partners they have.

Selected third-party funding since 2009

  • 2013-2016 | DFG
    SFB 829: Molekulare Grundlagen der Regulation der Homöostase der Haut - Teilprojekt A11: Rolle der Kontraktilität und des "sensing" der Zelldichte auf die Regulation der epidermalen Stratifizierung und der Gewebshomöostase
  • 2013-2017 | DFG
    CECAD: EXC 229 - to support collaborative research
  • 2011-2016 | European Research Council (ERC) FP7, Advanced Grant
    Genemit: Regulation of gene expression in mammalian mitochondria

  • 2011-2016 | European Research Council (ERC) FP7, Advanced Grant
    Experimental Research on Ageing

  • 2009-2016 | DFG
    SFB 829: Molecular mechanisms regulating skin homeostasis

  • 2013-2015 | Behrens-Weise Foundation
    Role of rigidity sensing in skin homeostasis and aging

  • 2012-2015 | NRW Academy of Arts and Sciences/Stiftung Mercator
    Skin homeostasis and ageing

  • 2011-2015 | BMBF
    GERONTOSYS - Forschungskern: SyBACol (Systems Biology of Ageing Cologne); Project Area A: Systems Biology of Longevity Pathways; Teilprojekt B

  • 2011-2015 | DFG
    SFB 635: Posttranslational control of protein function, Project C9: Regulation of C. elegans Developmental Timing by the F-box Protein  DRE-1/FBXO11

  • 2010-2015 | BMBF
    Virtual Liver Network

  • 2011-2014 | Max Planck Society
    Toxic Protein Confirmation: Ageing as a Risk Factor for Protein Toxicity in the Fruit Fly Drosophila

  • 2011-2013 | EU & MIWF NRW im Rahmen des aus dem EFRE ko-finanzierten Operationellen Programms für NRW im Ziel 2 "Regionale Wettbewerbsfähigkeit und Beschäftigung" 2007-2013
    Geweberegeneration: Vom Modellorganismus zur Therapie (joint with Sabine Eming, TaconicArtemis Pharmaceuticals GmbH)

  • 2011-2012 | DFG
    CECAD: Ageing in Drosophila

  • 2011-2012 | DFG
    CECAD Project: Metabolomic Profiling of C. elegans Longevity

  • 2009-2012 | DFG
    SFB 829: Molecular mechanisms regulating skin homeostasis - Pathophysiology of skin ageing and ageing-associated ulcerative dermatitis in mice